FFAR4 and lung adenocarcinoma: Multiple studies have demonstrated the presence of various FFAR4 mutations within populations [50, 51], and it is crucial to acknowledge that FFAR4 ligands can exert distinct effects on lung adenocarcinoma in these populations.